当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early PSA Response by 6 Months is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of TITAN Trial.
The Journal of Urology ( IF 5.9 ) Pub Date : 2024-07-26 , DOI: 10.1097/ju.0000000000004158
Soumyajit Roy 1 , Yilun Sun 2 , Kim N Chi 3 , Michael Ong 4 , Shawn Malone 4 , Christopher J D Wallis 5 , Amar U Kishan 6 , Julia Malone 4 , Umang Swami 7 , Georges Gebrael 7 , Jason R Brown 8 , Angela Y Jia 8 , Scott C Morgan 4 , Fred Saad 9 , Simon Chowdhury 10 , Neeraj Agarwal 7 , Daniel E Spratt 8
Affiliation  

Early PSA response has been found to be prognostic of outcome in metastatic hormone sensitive prostate cancer (mHSPC). We performed a secondary analysis of TITAN trial to determine if early PSA response was predictive of treatment efficacy in mHSPC patients.

中文翻译:


6 个月的早期 PSA 反应可预测转移性激素敏感前列腺癌的治疗效果:TITAN 试验的探索性分析。



已发现早期 PSA 反应预后于转移性激素敏感性前列腺癌 (mHSPC)。我们对 TITAN 试验进行了二次分析,以确定早期 PSA 反应是否能预测 mHSPC 患者的治疗效果。
更新日期:2024-07-26
down
wechat
bug